There are 398 resources available
17P - Clinicopathological and transcriptomic characterization of luminal HER2-enriched breast cancer
Presenter: Lennart Hohmann
Session: Poster Display session
18P - Comparative genomic profiling of primary and locally recurrent luminal breast cancers (BC)
Presenter: Elie Rassy
Session: Poster Display session
19P - Usefulness of Hounsfield Unit on computed tomography, serum neutrophil to lymphocyte ratio, and their combination as prognostic factor in patients with breast cancer.
Presenter: Airi Han
Session: Poster Display session
20P - The importance of ARG2 expression in the immune-depleted microenvironment of primary breast cancer and brain metastasis
Presenter: Athina Giannoudis
Session: Poster Display session
21P - Metabolomic profiling and response to neoadjuvant therapy in operable breast cancer
Presenter: Alessandra Gennari
Session: Poster Display session
22P - Biobanking in Breast Cancer: 10 years of practice at the European Institute of Oncology
Presenter: Giuseppe Viale
Session: Poster Display session
23P - In Vivo Multi-Dimensional CRISPR Screens Identify Lgals2 as an Immunotherapy Target in Triple-Negative Breast Cancer
Presenter: Peng Ji
Session: Poster Display session
24P - Intermediate biopsies during neoadjuvant chemotherapy for breast cancer to predict patient outcome
Presenter: Bruno Sinn
Session: Poster Display session
25P - Research-based HER2DX in patients with early-stage HER2-positive (HER2+) breast cancer treated in the N9831 phase III clinical trial
Presenter: Fara Brasó-Maristany
Session: Poster Display session
26P - Evaluation of tumor-infiltrating lymphocytes on matched baseline and residual disease samples of triple-negative breast cancer patients treated with anthracycline-taxane based neoadjuvant chemotherapy with or without carboplatin
Presenter: Federica Miglietta
Session: Poster Display session